These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26935837)

  • 21. Pituitary gigantism: Causes and clinical characteristics.
    Rostomyan L; Daly AF; Beckers A
    Ann Endocrinol (Paris); 2015 Dec; 76(6):643-9. PubMed ID: 26585365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics, clinical features and outcomes of non-syndromic pituitary gigantism: experience of a single center from Sao Paulo, Brazil.
    Trarbach EB; Trivellin G; Grande IPP; Duarte FHG; Jorge AAL; do Nascimento FBP; Garmes HM; Nery M; Mendonca BB; Stratakis CA; Bronstein MD; Jallad RS
    Pituitary; 2021 Apr; 24(2):252-261. PubMed ID: 33156432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary gigantism: update on molecular biology and management.
    Lodish MB; Trivellin G; Stratakis CA
    Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):72-80. PubMed ID: 26574647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are all Xq26.2 duplications overlapping GPC3 on array-CGH a cause of Simpson-Golabi-Behmel syndrome? When do we need transcript analysis?
    Vuillaume ML; Moizard MP; Hammouche E; Delrue MA; Perrin L; Maftei C; Dupont C; Drunat S; Cottereau E; Baumann C; Toutain A
    Clin Genet; 2018 May; 93(5):1111-1113. PubMed ID: 29372559
    [No Abstract]   [Full Text] [Related]  

  • 25. [Overgrowth in children and in adults: novel clinical view, novel genes, novel phenotypes].
    Lebl J; Plachý L; Bláhová K; Elblová L; Fencl F; Koloušková S; Průhová Š
    Cas Lek Cesk; 2017; 156(5):233-240. PubMed ID: 28992707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Array comparative genomic hybridisation analysis of boys with X linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3.
    Solomon NM; Ross SA; Morgan T; Belsky JL; Hol FA; Karnes PS; Hopwood NJ; Myers SE; Tan AS; Warne GL; Forrest SM; Thomas PQ
    J Med Genet; 2004 Sep; 41(9):669-78. PubMed ID: 15342697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: GPR101, an orphan GPCR with roles in growth and pituitary tumorigenesis.
    Trivellin G; Faucz FR; Daly AF; Beckers A; Stratakis CA
    Endocr Relat Cancer; 2020 Aug; 27(8):T87-T97. PubMed ID: 32240984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apparent Sotos syndrome (cerebral gigantism) in a child with trisomy 20p11.2-p12.1 mosaicism.
    Faivre L; Viot G; Prieur M; Turleau C; Gosset P; Romana S; Munnich A; Vekemans M; Cormier-Daire V
    Am J Med Genet; 2000 Apr; 91(4):273-6. PubMed ID: 10766982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GPR101: Modeling a constitutively active receptor linked to X-linked acrogigantism.
    Costanzi S; Stahr LG; Trivellin G; Stratakis CA
    J Mol Graph Model; 2024 Mar; 127():108676. PubMed ID: 38006624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. McCune-Albright syndrome: clinical and molecular evidence of mosaicism in an unusual giant patient.
    Tinschert S; Gerl H; Gewies A; Jung HP; Nürnberg P
    Am J Med Genet; 1999 Mar; 83(2):100-8. PubMed ID: 10190480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone Deficiency.
    Castinetti F; Daly AF; Stratakis CA; Caberg JH; Castermans E; Trivellin G; Rostomyan L; Saveanu A; Jullien N; Reynaud R; Barlier A; Bours V; Brue T; Beckers A
    Horm Metab Res; 2016 Jun; 48(6):389-93. PubMed ID: 26797872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paternal germline mosaicism for a GPC3 deletion in X-linked Simpson-Golabi-Behmel syndrome.
    Agatep R; Shuman C; Steele L; Parkinson N; Weksberg R; Stockley TL
    Am J Med Genet A; 2014 Oct; 164A(10):2682-4. PubMed ID: 25073799
    [No Abstract]   [Full Text] [Related]  

  • 33. DMD exon 2 duplication due to a complex genomic rearrangement is associated with a somatic mosaicism.
    Kubota A; Ishiura H; Porto KJL; Tanaka M; Mitsui J; Unuma A; Maki H; Komuro I; Tsuji S; Shimizu J; Toda T
    Neuromuscul Disord; 2022 Mar; 32(3):263-269. PubMed ID: 35093299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germline intergenic duplications at Xq26.1 underlie Bazex-Dupré-Christol basal cell carcinoma susceptibility syndrome.
    Liu Y; Banka S; Huang Y; Hardman-Smart J; Pye D; Torrelo A; Beaman GM; Kazanietz MG; Baker MJ; Ferrazzano C; Shi C; Orozco G; Eyre S; van Geel M; Bygum A; Fischer J; Miedzybrodzka Z; Abuzahra F; Rübben A; Cuvertino S; Ellingford JM; Smith MJ; Evans DG; Weppner-Parren LJMT; van Steensel MAM; Chaudhary IH; Mangham DC; Lear JT; Paus R; Frank J; Newman WG; Zhang X
    Br J Dermatol; 2022 Dec; 187(6):948-961. PubMed ID: 35986704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An update on the genetics of benign pituitary adenomas in children and adolescents.
    Hannah-Shmouni F; Stratakis CA
    Curr Opin Endocr Metab Res; 2018 Aug; 1():19-24. PubMed ID: 30555957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Chinese Case of X-Linked Acrogigantism and Systematic Review.
    Liang H; Gong F; Liu Z; Yang Y; Yao Y; Wang R; Wang L; Chen M; Pan H; Zhu H
    Neuroendocrinology; 2021; 111(12):1164-1175. PubMed ID: 33049741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parental somatic mosaicism for CNV deletions - A need for more sensitive and precise detection methods in clinical diagnostics settings.
    Liu Q; Karolak JA; Grochowski CM; Wilson TA; Rosenfeld JA; Bacino CA; Lalani SR; Patel A; Breman A; Smith JL; Cheung SW; Lupski JR; Bi W; Stankiewicz P
    Genomics; 2020 Sep; 112(5):2937-2941. PubMed ID: 32387503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paleogenetic study of ancient DNA suggestive of X-linked acrogigantism.
    Beckers A; Fernandes D; Fina F; Novak M; Abati A; Rostomyan L; Thiry A; Ouafik L; Pasture B; Pinhasi R; Daly AF
    Endocr Relat Cancer; 2017 Feb; 24(2):L17-L20. PubMed ID: 28049632
    [No Abstract]   [Full Text] [Related]  

  • 39. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene.
    Gadelha MR; Prezant TR; Une KN; Glick RP; Moskal SF; Vaisman M; Melmed S; Kineman RD; Frohman LA
    J Clin Endocrinol Metab; 1999 Jan; 84(1):249-56. PubMed ID: 9920092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.